Therapeutic Angiogenesis and Vasculogenesis for Ischemic Disease
Reference73 articles.
1. Aebischer, P., Salessiotis, A.N., and Winn, S.R. 1989. Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J. Neurosci. Res. 23:282-289. 2. Asahara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G.D., and Isner, J.M. 1998. Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83:342-343. 3. Banai, S., Shweiki, D., Pinson, A., Chandra, M., Lazarovici, G., and Keshet, E. 1974. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc. Res 28:1176-1179. 4. Banai, S., Jaklitsch, M.T., Casscells, W., Shou, M., Shrivastav, S., Correa, R., Epstein, S.E., and Unger, E.F. 1991. Effects of acidic fibroblast growth factor on normal and ischemic my-ocardium. Circ. Res. 69:76-85. 5. Bender, J.G., Unverzagt, K.L., Walker, D.E., Lee, W., Van Epps, D.E., Smith, D.H., Stewart, C.C., and To, L.B. 1991. Identification and comparison of CD34-positive cells and their subpopula-tions from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591-2596.
|
|